Automated Cell Counter Market Analysis and Forecast to 2031: By Product Type (Flow Cytometers, Fluorescence Image-Based Cell Counter, Coulter Counter), Application (Blood Cells, Cell Lines, Microbial Cells, Others), End Use (Pharmaceutical & Biotechnology

Automated Cell Counter Market Analysis and Forecast to 2031: By Product Type (Flow Cytometers, Fluorescence Image-Based Cell Counter, Coulter Counter), Application (Blood Cells, Cell Lines, Microbial Cells, Others), End Use (Pharmaceutical & Biotechnology Companies, Hospitals, Diagnostic Laboratories, Research Institutes, Others), and Region

The global automated cell counter market was valued at USD 6.9 Billion in 2021 and it is anticipated to grow further till USD 12.2 Billion in 2031, at a CAGR of 5.9% during the forecast period.

Numerous research fields, including neurology, cancer biology, and immunology, which have lucrative market growth prospects, are gradually adopting cell counting tools. Blood cell counting is essential for the evaluation of numerous diseases, and its usage is likely to rise throughout the forecast period, therefore the market is also expected to experience exponential growth. They are moreover widely employed in cancer research to control intra-tumour heterogeneity, which is crucial for figuring out how cancer progresses. For the purpose of disease monitoring and treatment targeting, cell counting is useful in identifying and classifying primary tumours, circulating tumours, and metastatic cancers.
Global Automated Cell Counter Market Scope and Report Structure
Market Trends and Drivers
The global automated cell counting market is expanding as a result of the increasing incidence of chronic and infectious diseases like cancer, AIDS, sepsis, malaria, influenza, measles, cholera, and vector-borne illnesses like chikungunya and polio. The market for automated cell counting will rise as the need for cell counting in the diagnosis and treatment of such fatal diseases increases. The World Health Organization (WHO) estimates that at the end of 2020, in November 2021, there were around 37.7 million HIV-positive individuals worldwide. Additionally, 680,000 individuals died in 2020 from HIV-related causes, according to the same source. As a result, the market growth is anticipated to be greatly boosted by the rising prevalence of infectious diseases.
Market Restraints and Challenges
The price of automated cell counter systems is increasing due to ongoing technological advancements made to eliminate errors and increase efficiency. For instance, the cost of a flow cytometer gadget ranges from USD 75,000 to USD 90,000. Automated cell counter usage is slowing down as a result of the growth in accessory and device prices, which is a significant issue that could limit industry revenue.

Global Automated Cell Counter Market Segmental Overview
The report analyses the global automated cell counter market based on the product type, application, end use, and region.

Global Automated Cell Counter Market by Product Type

Based on the product type, it is segmented into flow cytometers, fluorescence image-based cell counter, and coulter counter. The fluorescence segment is anticipated to dominate the market during the forecast period. Image-based cell counters are far more effective than their flow-based equivalents for general-purpose cell counting applications. Additionally, they are substantially more cost-effective, easy to use, and require little upkeep. These outstanding product characteristics, along with the rising prevalence of UTIs (Urinary Tract Infections), diabetes, kidney disease, and other chronic ailments, could result in significant profits for the sector.

Global Automated Cell Counter Market by Application

The automated cell counter market is segmented based on applications into blood cells, cell lines, microbial cells, and others. The blood cell market had the leading position in 2021 and is anticipated to grow at a profitable CAGR over the next few years. Because blood cell counting is widely used to assess a person's general health, it has become a reliable and efficient approach throughout the healthcare industry. The method has shown to be useful in identifying a number of medical conditions, including infection, anaemia, and leukaemia, which is driving the demand for automated cell counts for blood cells. These applications span a wide range of clinical and research practises.

Global Automated Cell Counter Market by End Use

Based on the end use, it is segmented into hospitals, diagnostic laboratories, research institutes, pharmaceuticals & biotechnology companies, and others. The diagnostic laboratories segment is anticipated to dominate the market during the forecast period. With the use of expert personnel, certified medical professionals, and cutting-edge laboratory equipment, diagnostic facilities assist patients with specific signs or symptoms in identifying diseases. The rising number of people, of all ages and genders, receiving disease diagnoses in these settings will significantly accelerate the segment's growth.
Geographical Analysis of the Global Automated Cell Counter Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. The North America is anticipated to hold the dominant position during the forecast period. One of the key factors influencing the use of these devices is the rise in the prevalence of chronic diseases, such as blood and cardiovascular disorders. According to the American National Red Cross, 90,000 to 100,000 Americans are affected by sickle cell disease.
Major Players in the Global Automated Cell Counter Market
The key players studied in the report are Abbott Laboratories, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc, Danaher (Beckman Coulter Inc. and Radiometer), Sysmex Corporation, NanoEnTek, F. Hoffmann-La Roche Ltd, Olympus Corporation, Agilent Technologies, Inc., and PerkinElmer, Inc. among others.
COVID-19 Impact
The automated cell counter industry benefited from the start of the COVID-19 pandemic. There is a growing need for automated cell counters as a result of the unpredictable clinical course of the coronaviral infection and the lack of any preventive therapies or treatments. These factors have led to an increase in research & development projects in the biomedical and life science fields. It has become a common clinical practise to assess the severity of an illness by analysing many haematological indicators, such as haemoglobin, platelets, lymphocytes, white blood cell count, neutrophils, and white blood cell count.
Recent Developments

May 2021, Bio-Rad Laboratories Inc., announced a partnership with major diagnostic companies through offering InteliQ products, a range of barcoded, load-and go quality control tubes. For instance, the partnership with Roche offers customers access to Bio-Rad’s complete line of InteliQ products and Unity QC data management solutions and customer training & support services.
April 2021, Eppendorf announced the launch of new product, “Centrifuge 5910 Ri” designed to increase laboratory efficiency. This new centrifuge is a successor to the popular Centrifuge 5910 R, and is a flagship of Eppendorf’s multipurpose centrifuge portfolio that others scientist advanced features to simplify and accelerate the centrifugation steps.
August 2019, Agilent Technologies, Inc. announced the acquisition of Biotek Instruments, a pioneer in the design, manufacture, and distribution of innovative life science instrumentation.

Frequently Asked Questions
Q1. How big is the Automated Cell Counter market?

Ans. The global Automated Cell Counter market size was USD 6.9 Billion in 2021 and is anticipated to reach USD 12.2 Billion in 2031, growing at a rate of 5.2% from 2022 to 2031.

Q2. What is the Automated Cell Counter market growth rate?

Ans. The growth rate of the Automated Cell Counter market is 5.2%.

Q3. Which region holds a major market share for the Automated Cell Counter market?

Ans. North America holds a major market share of the Automated Cell Counter market in 2021.

Q4. Which segment accounted for the largest Automated Cell Counter market share?

Ans. By application, the blood cells segment accounted for the largest Automated Cell Counter market share.

Q5. Who are the key players in the Automated Cell Counter market?

Ans. The global Automated Cell Counter market report includes players such as Abbott Laboratories, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc, Danaher (Beckman Coulter Inc. and Radiometer), Sysmex Corporation, NanoEnTek, F. Hoffmann-La Roche Ltd, Olympus Corporation, Agilent Technologies, Inc., and PerkinElmer, Inc. among others.

Q6. What are the factors driving the Automated Cell Counter market growth?

Ans. The major factors driving the growth of the market are the growing healthcare market in emerging countries.

Q7. What are the key growth strategies of Automated Cell Counter market players?

Ans. The key growth strategies of Automated Cell Counter market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the Automated Cell Counter market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the Automated Cell Counter market during the forecast period.



Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.